News
-
In Silico World - in silico resources to fight coronavirus
A dedicated page on "In Silico World" collects all initiatives of the In Silico community toward the fight against coronavirus.
-Read more-
-
Recommendations on modelling and simulations in the new EMA Regulatory Science Strategy to 2025
In the "Regulatory Science Strategy to 2025", the European Medicine Agency included specific recommendation to optimise the capabilities of modelling and simulation in the drug development process.
-Read more-
-
Verifying and Validating Quantitative Systems Pharmacology and In Silico Models in Drug Development
A commentary paper has recently been published in "CPT: Pharmacometrics & Systems Pharmacology" reporting the outcome of a multistakeholder workshop on the validation challenges for in silico models in drug development. The event was organized on 25 - 26 April 2019 in (Leuven) Belgium in collaboration with the VPH Institute.
-Read more-
-
How supercomputers could help finding a treatments for COVID-19
Science Focus explains how supercomputer are playing an important part in urgent research into coronavirus, which could help speed up the development of treatments.
-Read more-
-
Exscalate4CoV uses the power of supercomputer to find potential treatments against COVID-19
The Exscalate4CoV project is using the most powerful computing resources currently based in Europe to empower smart in-silico drug design.
-Read more-
-
Roadmap on General Data Protection Regulation (GDPR)
On 1 April 2020 the European Commission launched a Roadmap on DGPR and opened it to the feedback of stakeholders whose input will ultimately feed into the Commission’s report. For those interested to contribute the deadline is 29 April 2020.
-Read more-
